Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of combination of anti-PD-1 antibody and VEGFR inhibitor in preparation of drug for treating cancers

Use of combination of anti-PD-1 antibody and VEGFR inhibitor in preparation of drug for treating cancers

US Patent 11866500 · Granted Jan 9, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Humanized monoclonal antibody targeting BCMA and having human monkey cross-react2025
Use of combination of anti-PD-1 antibody and VEGFR inhibitor in preparation of d2025
Cyclic molecules as Bruton's tyrosine kinase inhibitor2025
Use of anti-PD-1 antibody in combination with famitinib in preparation of drug f2025
Use of anti-PD-1 antibody in combination with famitinib in preparation of drug f2025
Anti-OX40 antibody, antigen-binding fragment thereof, and the pharmaceutical use2025
Human IL-4R binding antibody, antigen binding fragment thereof, and medical use 2024
LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application2024
PD-L1 antibody, antigen-binding fragment thereof and medical application thereof2023
PD-L1 antibody, antigen-binding fragment thereof and medical application thereof2023
Interleukin 15 protein complex and use thereof2023
B7-H3 antibody, antigen-binding fragment thereof and medical use thereof2023